DermBiont, Inc.

DermBiont, Inc. pioneering the world’s leading precision dermatology company developing targeted topical therapeutics that address the root cause of skin diseases. Mining our curated library of microbes to build a pipeline of products to treat identified dysbiosis across indications. Bacteria, fungi and other microorganisms reside in the upper, or superficial, layers of skin, as well as on hair follicles. They survive on dead skin and oily secretions shed by healthy tissue. Skin has evolved to support a diversity of microbes, which outcompete pathogens, preventing them from entering the body and causing disease. DermBiont serves customers in the United States.